Let’s start up with the current stock price of Arbutus Biopharma Corporation (ABUS), which is $4.30 to be very precise. The Stock rose vividly during the last session to $4.90 after opening rate of $4.89 while the lowest price it went was recorded $4.32 before closing at $4.53.
Recently in News on November 16, 2020, Arbutus Announces Additional Robust HBsAg Decline Data with AB-729 in Chronic Hepatitis B Subjects. Data released today expands on November 15, 2020 AASLD presentation. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Arbutus Biopharma Corporation had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $9.02 on 07/24/20, with the lowest value was $0.88 for the same time period, recorded on 04/03/20.
Arbutus Biopharma Corporation (ABUS) full year performance was 171.26%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Arbutus Biopharma Corporation shares are logging -52.37% during the 52-week period from high price, and 388.22% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.88 and $9.02.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3375343 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Arbutus Biopharma Corporation (ABUS) recorded performance in the market was 62.95%, having the revenues showcasing 55.67% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 334.13M, as it employees total of 80 workers.
The Analysts eye on Arbutus Biopharma Corporation (ABUS)
During the last month, 0 analysts gave the Arbutus Biopharma Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.21, with a change in the price was noted +2.45. In a similar fashion, Arbutus Biopharma Corporation posted a movement of +131.99% for the period of last 100 days, recording 6,521,677 in trading volumes.
Technical rundown of Arbutus Biopharma Corporation (ABUS)
Raw Stochastic average of Arbutus Biopharma Corporation in the period of last 50 days is set at 73.17%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 72.66%. In the last 20 days, the company’s Stochastic %K was 81.24% and its Stochastic %D was recorded 80.52%.
Considering, the past performance of Arbutus Biopharma Corporation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 62.95%. Additionally, trading for the stock in the period of the last six months notably improved by 116.75%, alongside a boost of 171.26% for the period of the last 12 months. The shares increased approximately by 34.82% in the 7-day charts and went down by 54.08% in the period of the last 30 days. Common stock shares were driven by 55.67% during last recorded quarter.